Kortuc 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
hydrogen peroxide (KRC-01) / Kortuc
2019-001709-25: The KORTUC phase II Trial (Phase II trial testing efficacy of intra-tumoural hydrogen peroxide as a radiation sensitiser in patients with locally advanced and recurrent breast cancer)

Not yet recruiting
2
184
Europe
Hydrogen Peroxide Solution 3% BP 10 Vols, Solution for injection, Hydrogen Peroxide Solution 3% BP 10 Vols
The Institute of Cancer Research
Patients with locally advanced/recurrent breast cancer, Breast cancer, Diseases [C] - Cancer [C04]
 
 
NCT03946202: KORTUC Phase II - Intra-tumoural Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer

Recruiting
2
184
Europe, RoW
Hydrogen Peroxide
Institute of Cancer Research, United Kingdom, Kortuc, Inc.
Breast Cancer
11/27
11/27
NCT05570422: A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01

Not yet recruiting
1
70
Europe, RoW
KRC-01, External Beam Radiation Therapy, cisplatin, Chemotherapy, brachytherapy
Kortuc, Inc.
Cervical Cancer
01/27
03/27

Download Options